Testing effectiveness (Phase 2)WithdrawnNCT06489340
What this trial is testing
P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease
Who this might be right for
Diabetic Kidney Disease
ZyVersa Therapeutics, Inc.
Showing 15 of 0 results